Stockreport

Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF This compares to loss of $0.76 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 6.94% [Read more]